Dr. Maryna Yaskina (Biostatistician with WHCRI) and Dr. Michael Chu (Clinician Scientist at the Cross Cancer Institute) will present on design, approach and benefits of adaptive clinical trials. After an overview by Dr. Yaskina, Dr. Chu will present a case study of a Car T-cell intervention clinical trial.
For more information contact Dr. Carol Ladner-Keay.